Close

This is a StreetInsider.com Premium Only Page

Please sign-up to enjoy all the benefits of StreetInsider.com Premium or log-in if you're already a member.

Send to a Friend Font Size: Increase Decrease

Back to PDSB Stock Lookup

(PDSB) – Hot FDA News

May 25, 2023 05:04 PM PDS Biotechnology (PDSB) Announces Interim Data Demonstrates 12-Month Survival Rate of 87% with PDS0101 in Combination with KEYTRUDA for Head and Neck Cancer Patients
Nov 14, 2022 07:09 AM PDS Biotechnology (PDSB) Announces 100% Clinical Response in Cervical Cancer Patients in Preliminary Data from IMMUNOCERV Phase 2 Clinical Trial
Jun 2, 2022 08:59 AM
Jul 27, 2020 08:31 AM

Back to PDSB Stock Lookup